Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

BIO: Trump’s Part B pricing scheme ‘undermines the incentive to innovate’

We will not stand behind non-competitive pricing schemes that undermine the incentive to innovate and invest in drug development, says BIO VP of industry research, David Thomas.

AstraZeneca sells US rights to RSV drug for $1.5bn

AstraZeneca announced it will sell US rights to Synagis to Sobi, to focus on its collaborative RSV therapy.

US FDA warning: Illegally marketed stem cell therapy made in substandard lab

California-based StemGenex marketed its SVF drug without an approved biologics license application, according to the agency.

Medicon Valley: How Denmark and Sweden are ‘bridging’ the biotech gap

The Nordic life science cluster aspires to become the most prominent in northern Europe, says Medicon Valley Alliance executive.

‘Illegal and corrupt advantage’: Federal grand jury serves criminal theft charges to JHL Biotech

Former Genentech employees and a JHL employee were served criminal charges related to the theft of Genentech’s proprietary information.

Global Industry News

Hot Topics

Spotlight

First-in-man study appears to ‘awaken’ dormant hair follicles, says biotech

GE Healthcare strengthens single-use manufacturing in China

WuXi Biologics' Biologics Center of Excellence (MFG8) in Shijiazhuan, China

WuXi Biologics breaks ground on $240m manufacturing site near Beijing

Coherus receives US FDA approval for Neulasta biosimilar, pricing 33% lower

#BIOEurope: ‘Deal making is off the charts and the IPO window is open’

Products

Webinars

On-demand webinars

Marken: Global Life Science Supply Chain Solutions Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories

Marken: Global Life Science Supply Chain Solutions

Merck KGaA, Darmstadt, Germany

Samsung BioLogics